Cost-Effectiveness of Primary Prevention with Statin Treatment for Chinese Patients with Type 2 Diabetes

被引：0
|
作者：
Te Li
Xu Wan
Jin Ma
Bin Wu
机构：
[1] Fuwai Yunnan Cardiovascular Hospital,Department of Pharmacy
[2] Affiliated with the Kunming Medical University,Department of Pharmacy, Ren Ji Hospital, South Campus, School of Medicine
[3] Shanghai Jiaotong University,Department of Endocrinology, Ren Ji Hospital, School of Medicine
[4] Shanghai Jiaotong University,undefined
来源：
Advances in Therapy | 2018年 / 35卷
关键词：
Cost-effectiveness; Chinese setting; Diabetes; Statin treatment; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2214 / 2223
页数：9
相关论文
共 50 条
  • [1] Cost-Effectiveness of Primary Prevention with Statin Treatment for Chinese Patients with Type 2 Diabetes
    Li, Te
    Wan, Xu
    Ma, Jin
    Wu, Bin
    ADVANCES IN THERAPY, 2018, 35 (12) : 2214 - 2223
  • [2] Cost-effectiveness of primary prevention of type 2 diabetes
    Icks, A.
    Chernyak, N.
    Klein, A.
    Brinks, R.
    Genz, J.
    Giani, G.
    DIABETOLOGE, 2011, 7 (02): : 92 - 98
  • [3] COST-EFFECTIVENESS OF STATINS FOR PRIMARY PREVENTION IN PATIENTS NEWLY DIAGNOSED WITH TYPE 2 DIABETES IN THE CHINESE CONTEXT
    Wu, B.
    Ma, J.
    Xie, X.
    VALUE IN HEALTH, 2018, 21 : S39 - S39
  • [4] COST-EFFECTIVENESS OF ASPIRIN FOR PRIMARY PREVENTION OF CARDIOVASCULAR EVENTS IN CHINESE PATIENTS WITH DIABETES
    Jiang, M.
    Li, P.
    Zheng, X.
    Deng, J.
    Zhao, M.
    Fang, Y.
    VALUE IN HEALTH, 2019, 22 : S129 - S129
  • [5] COST-EFFECTIVENESS OF CANAGLIFLOZIN TREATMENT IN CHINESE PATIENTS WITH TYPE 2 DIABETES AND KIDNEY DISEASE
    Wu, B.
    VALUE IN HEALTH, 2019, 22 : S584 - S584
  • [6] COST-EFFECTIVENESS OF STATINS FOR PRIMARY PREVENTION IN NEWLY DIAGNOSED TYPE 2 DIABETES PATIENTS IN THE NETHERLANDS
    de Vries, F. M.
    Denig, P.
    Visser, S. T.
    Hak, E.
    Postma, M. J.
    VALUE IN HEALTH, 2013, 16 (07) : A526 - A526
  • [7] Cost-Effectiveness of Statins for Primary Prevention in Patients Newly Diagnosed with Type 2 Diabetes in The Netherlands
    de Vries, Folgerdiena M.
    Denig, Petra
    Visser, Sipke T.
    Hak, Eelko
    Postma, Maarten J.
    VALUE IN HEALTH, 2014, 17 (02) : 223 - 230
  • [8] Cost-effectiveness of primary prevention of type 2 diabetes. A systematic review
    Klein, A.
    Chernyak, N.
    Brinks, R.
    Genz, J.
    Icks, A.
    PRAVENTION UND GESUNDHEITSFORDERUNG, 2011, 6 (02): : 102 - 110
  • [9] Cost-Effectiveness of Primary Prevention of Type 2 Diabetes: An Update of Systemetic Review
    Li, Rui
    Zhang, Ping
    DIABETES, 2013, 62 : A325 - A325
  • [10] Cost-effectiveness of treatment of type 2 diabetes
    Eastman, RC
    DIABETES CARE, 1998, 21 (03) : 464 - 465
12345